Total Payments
$567.85
2024 Payments
$115.62
Companies
6
Transactions
31
Payment Breakdown by Category
Food & Beverage$567.85 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $567.85 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $337.73 | 19 | $0 (2024) |
| ABBVIE INC. | $106.45 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $41.14 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.66 | 2 | $0 (2024) |
| Tris Pharma Inc | $23.48 | 1 | $0 (2021) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.39 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.62 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($39.66) |
| 2023 | $218.81 | 10 | Supernus Pharmaceuticals, Inc. ($152.13) |
| 2022 | $25.17 | 2 | Supernus Pharmaceuticals, Inc. ($25.17) |
| 2021 | $208.25 | 14 | Supernus Pharmaceuticals, Inc. ($125.40) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $35.03 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/19/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $34.50 | General |
| Category: PSYCHOLOGY | ||||||
| 10/19/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $44.37 | General |
| Category: PSYCHOLOGY | ||||||
| 09/13/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $28.66 | General |
| Category: PSYCHOLOGY | ||||||
| 07/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: PSYCHOLOGY | ||||||
| 03/20/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: PSYCHOLOGY | ||||||
| 02/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $10.82 | General |
| Category: PSYCHOLOGY | ||||||
| 07/22/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: PSYCHOLOGY | ||||||
| 05/13/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.05 | General |
| Category: PSYCHOLOGY | ||||||
| 12/17/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: PSYCHOLOGY | ||||||
| 12/14/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.55 | General |
| Category: PSYCHOLOGY | ||||||
| 11/10/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.61 | General |
| Category: PSYCHOLOGY | ||||||
| 10/19/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $8.63 | General |
| Category: PSYCHOLOGY | ||||||
| 10/07/2021 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: ADHD | ||||||
| 10/04/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $18.96 | General |
| Category: PSYCHOLOGY | ||||||
| 09/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Michael Swaney, MD
Dr. Michael Swaney, MD is a Child & Adolescent Psychiatry healthcare provider based in Saint Simons Island, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477580801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Swaney, MD has received a total of $567.85 in payments from pharmaceutical and medical device companies, with $115.62 received in 2024. These payments were reported across 31 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($567.85).
Ad
Practice Information
- Specialty Child & Adolescent Psychiatry
- Other Specialties Psychiatry
- Location Saint Simons Island, GA
- Active Since 06/28/2006
- Last Updated 07/21/2022
- Taxonomy Code 2084P0804X
- Entity Type Individual
- NPI Number 1477580801
Products in Payments
- QELBREE (Drug) $302.70
- VRAYLAR (Drug) $106.45
- TRINTELLIX (Drug) $39.66
- Qelbree (Drug) $35.03
- Dyanavel XR (Drug) $23.48
- REXULTI (Drug) $21.38
- ABILIFY MAINTENA (Drug) $19.76
- CAPLYTA (Drug) $19.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.